P1043: OUTCOME OF PATIENTS WITH PREFIBROTIC MYELOFIBROSIS FROM A LARGE ACADEMIC CENTER

por Masarova, L., Bose, P., Pemmaraju, N., Chifotides, H., Zhou, L., Estrov, Z., Kantarjian, H., Verstovsek, S.
Publicado 2022

P1052: IMPACT OF SF3B1 MUTATION IN MYELOFIBROSIS

por Senapati, J., Verstovsek, S., Masarova, L., Pemmaraju, N., Montalban Bravo, G., Pierce, S., Zhou, L., Garcia-Manero, G., Kantarjian, H., Bose, P.
Publicado 2022

P1066: OUTCOMES OF COVID-19 IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS - AN OBSERVATIONAL COHORT STUDY FROM A LARGE ACADEMIC CANCER CENTER IN THE UNITED STATES

por Venugopal, S., Song, H., Young, C., Cutherell, M. A., Baganz, J. A., Zatorsky, S., Woodman, S. E., Pemmaraju, N., Bose, P., Masarova, L., Zhou, L., Pierce, S., Kantarjian, H., Verstovsek, S.
Publicado 2022